Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.
Identifieur interne : 000A03 ( PubMed/Checkpoint ); précédent : 000A02; suivant : 000A04Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.
Auteurs : M A Beek [Pays-Bas] ; E. Tetteroo [Pays-Bas] ; E J T. Luiten [Pays-Bas] ; P D Gobardhan [Pays-Bas] ; H J T. Rutten [Pays-Bas] ; J B Heijns [Pays-Bas] ; A C Voogd [Pays-Bas] ; E G Klompenhouwer [Pays-Bas]Source :
- European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [ 1532-2157 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aisselle (), Aisselle (anatomopathologie), Complications postopératoires (), Composés hétérocycliques, Composés organométalliques, Femelle, Humains, Imagerie par résonance magnétique (), Lymphadénectomie, Lymphoedème (), Maladie résiduelle (diagnostic), Métastase lymphatique (anatomopathologie), Pays-Bas, Produits de contraste, Résultat thérapeutique, Sujet âgé, Traitement médicamenteux adjuvant, Traitement néoadjuvant, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (traitement médicamenteux), Études rétrospectives.
- MESH :
- anatomopathologie : Aisselle, Métastase lymphatique, Tumeurs du sein.
- diagnostic : Maladie résiduelle.
- traitement médicamenteux : Tumeurs du sein.
- Adulte, Adulte d'âge moyen, Aisselle, Complications postopératoires, Composés hétérocycliques, Composés organométalliques, Femelle, Humains, Imagerie par résonance magnétique, Lymphadénectomie, Lymphoedème, Pays-Bas, Produits de contraste, Résultat thérapeutique, Sujet âgé, Traitement médicamenteux adjuvant, Traitement néoadjuvant, Tumeurs du sein, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Aged, Axilla (pathology), Axilla (surgery), Breast Neoplasms (drug therapy), Breast Neoplasms (pathology), Breast Neoplasms (surgery), Chemotherapy, Adjuvant, Contrast Media, Female, Heterocyclic Compounds, Humans, Lymph Node Excision, Lymphatic Metastasis (pathology), Lymphedema (prevention & control), Magnetic Resonance Imaging (methods), Middle Aged, Neoadjuvant Therapy, Neoplasm, Residual (diagnosis), Netherlands, Organometallic Compounds, Postoperative Complications (prevention & control), Retrospective Studies, Treatment Outcome.
- MESH :
- chemical : Contrast Media, Heterocyclic Compounds, Organometallic Compounds.
- diagnosis : Neoplasm, Residual.
- drug therapy : Breast Neoplasms.
- methods : Magnetic Resonance Imaging.
- pathology : Axilla, Breast Neoplasms, Lymphatic Metastasis.
- prevention & control : Lymphedema, Postoperative Complications.
- surgery : Axilla, Breast Neoplasms.
- Adult, Aged, Chemotherapy, Adjuvant, Female, Humans, Lymph Node Excision, Middle Aged, Neoadjuvant Therapy, Netherlands, Retrospective Studies, Treatment Outcome.
Abstract
Axillary reverse mapping (ARM) is a technique that discerns axillary lymphatic drainage of the arm from the breast. In the current study, we retrospectively evaluated the incidence of metastatic axillary lymph node involvement, including ARM lymph nodes, in clinically node positive breast cancer patients (cN+ patients) in whom neo-adjuvant chemotherapy (NAC) was administered followed by primary ALND using breast MRI.
DOI: 10.1016/j.ejso.2016.02.005
PubMed: 26898838
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:26898838Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.</title><author><name sortKey="Beek, M A" sort="Beek, M A" uniqKey="Beek M" first="M A" last="Beek">M A Beek</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Breda, The Netherlands. Electronic address: MBeek@amphia.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Tetteroo, E" sort="Tetteroo, E" uniqKey="Tetteroo E" first="E" last="Tetteroo">E. Tetteroo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Amphia Hospital, Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Radiology, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Luiten, E J T" sort="Luiten, E J T" uniqKey="Luiten E" first="E J T" last="Luiten">E J T. Luiten</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Gobardhan, P D" sort="Gobardhan, P D" uniqKey="Gobardhan P" first="P D" last="Gobardhan">P D Gobardhan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Rutten, H J T" sort="Rutten, H J T" uniqKey="Rutten H" first="H J T" last="Rutten">H J T. Rutten</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht</wicri:regionArea><wicri:noRegion>Maastricht</wicri:noRegion></affiliation></author><author><name sortKey="Heijns, J B" sort="Heijns, J B" uniqKey="Heijns J" first="J B" last="Heijns">J B Heijns</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Amphia Hospital, Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Oncology, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Voogd, A C" sort="Voogd, A C" uniqKey="Voogd A" first="A C" last="Voogd">A C Voogd</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Department of Research, Netherlands Comprehensive Cancer Organisation, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Department of Research, Netherlands Comprehensive Cancer Organisation</wicri:regionArea><wicri:noRegion>Netherlands Comprehensive Cancer Organisation</wicri:noRegion></affiliation></author><author><name sortKey="Klompenhouwer, E G" sort="Klompenhouwer, E G" uniqKey="Klompenhouwer E" first="E G" last="Klompenhouwer">E G Klompenhouwer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, The Netherlands Cancer Institute, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Radiology, The Netherlands Cancer Institute</wicri:regionArea><wicri:noRegion>The Netherlands Cancer Institute</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26898838</idno><idno type="pmid">26898838</idno><idno type="doi">10.1016/j.ejso.2016.02.005</idno><idno type="wicri:Area/PubMed/Corpus">000992</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000992</idno><idno type="wicri:Area/PubMed/Curation">000992</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000992</idno><idno type="wicri:Area/PubMed/Checkpoint">000992</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000992</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.</title><author><name sortKey="Beek, M A" sort="Beek, M A" uniqKey="Beek M" first="M A" last="Beek">M A Beek</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Breda, The Netherlands. Electronic address: MBeek@amphia.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Tetteroo, E" sort="Tetteroo, E" uniqKey="Tetteroo E" first="E" last="Tetteroo">E. Tetteroo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, Amphia Hospital, Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Radiology, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Luiten, E J T" sort="Luiten, E J T" uniqKey="Luiten E" first="E J T" last="Luiten">E J T. Luiten</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Gobardhan, P D" sort="Gobardhan, P D" uniqKey="Gobardhan P" first="P D" last="Gobardhan">P D Gobardhan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Amphia Hospital, Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Rutten, H J T" sort="Rutten, H J T" uniqKey="Rutten H" first="H J T" last="Rutten">H J T. Rutten</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht</wicri:regionArea><wicri:noRegion>Maastricht</wicri:noRegion></affiliation></author><author><name sortKey="Heijns, J B" sort="Heijns, J B" uniqKey="Heijns J" first="J B" last="Heijns">J B Heijns</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Amphia Hospital, Breda, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Oncology, Amphia Hospital, Breda</wicri:regionArea><wicri:noRegion>Breda</wicri:noRegion></affiliation></author><author><name sortKey="Voogd, A C" sort="Voogd, A C" uniqKey="Voogd A" first="A C" last="Voogd">A C Voogd</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Department of Research, Netherlands Comprehensive Cancer Organisation, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Department of Research, Netherlands Comprehensive Cancer Organisation</wicri:regionArea><wicri:noRegion>Netherlands Comprehensive Cancer Organisation</wicri:noRegion></affiliation></author><author><name sortKey="Klompenhouwer, E G" sort="Klompenhouwer, E G" uniqKey="Klompenhouwer E" first="E G" last="Klompenhouwer">E G Klompenhouwer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Radiology, The Netherlands Cancer Institute, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Radiology, The Netherlands Cancer Institute</wicri:regionArea><wicri:noRegion>The Netherlands Cancer Institute</wicri:noRegion></affiliation></author></analytic><series><title level="j">European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</title><idno type="eISSN">1532-2157</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Axilla (pathology)</term><term>Axilla (surgery)</term><term>Breast Neoplasms (drug therapy)</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (surgery)</term><term>Chemotherapy, Adjuvant</term><term>Contrast Media</term><term>Female</term><term>Heterocyclic Compounds</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphatic Metastasis (pathology)</term><term>Lymphedema (prevention & control)</term><term>Magnetic Resonance Imaging (methods)</term><term>Middle Aged</term><term>Neoadjuvant Therapy</term><term>Neoplasm, Residual (diagnosis)</term><term>Netherlands</term><term>Organometallic Compounds</term><term>Postoperative Complications (prevention & control)</term><term>Retrospective Studies</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle ()</term><term>Aisselle (anatomopathologie)</term><term>Complications postopératoires ()</term><term>Composés hétérocycliques</term><term>Composés organométalliques</term><term>Femelle</term><term>Humains</term><term>Imagerie par résonance magnétique ()</term><term>Lymphadénectomie</term><term>Lymphoedème ()</term><term>Maladie résiduelle (diagnostic)</term><term>Métastase lymphatique (anatomopathologie)</term><term>Pays-Bas</term><term>Produits de contraste</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Traitement médicamenteux adjuvant</term><term>Traitement néoadjuvant</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs du sein (traitement médicamenteux)</term><term>Études rétrospectives</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Contrast Media</term><term>Heterocyclic Compounds</term><term>Organometallic Compounds</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Aisselle</term><term>Métastase lymphatique</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Neoplasm, Residual</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Maladie résiduelle</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Magnetic Resonance Imaging</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Axilla</term><term>Breast Neoplasms</term><term>Lymphatic Metastasis</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphedema</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Axilla</term><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Chemotherapy, Adjuvant</term><term>Female</term><term>Humans</term><term>Lymph Node Excision</term><term>Middle Aged</term><term>Neoadjuvant Therapy</term><term>Netherlands</term><term>Retrospective Studies</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Complications postopératoires</term><term>Composés hétérocycliques</term><term>Composés organométalliques</term><term>Femelle</term><term>Humains</term><term>Imagerie par résonance magnétique</term><term>Lymphadénectomie</term><term>Lymphoedème</term><term>Pays-Bas</term><term>Produits de contraste</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Traitement médicamenteux adjuvant</term><term>Traitement néoadjuvant</term><term>Tumeurs du sein</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Axillary reverse mapping (ARM) is a technique that discerns axillary lymphatic drainage of the arm from the breast. In the current study, we retrospectively evaluated the incidence of metastatic axillary lymph node involvement, including ARM lymph nodes, in clinically node positive breast cancer patients (cN+ patients) in whom neo-adjuvant chemotherapy (NAC) was administered followed by primary ALND using breast MRI.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26898838</PMID><DateCreated><Year>2016</Year><Month>04</Month><Day>13</Day></DateCreated><DateCompleted><Year>2016</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>5</Issue><PubDate><Year>2016</Year><Month>May</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.</ArticleTitle><Pagination><MedlinePgn>672-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2016.02.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(16)00099-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Axillary reverse mapping (ARM) is a technique that discerns axillary lymphatic drainage of the arm from the breast. In the current study, we retrospectively evaluated the incidence of metastatic axillary lymph node involvement, including ARM lymph nodes, in clinically node positive breast cancer patients (cN+ patients) in whom neo-adjuvant chemotherapy (NAC) was administered followed by primary ALND using breast MRI.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">Data from 98 cN+ breast cancer patients were analysed retrospectively. Patients without residual axillary disease at breast MRI following NAC (RAD-, n = 64) were compared with patients with residual axillary disease (RAD+, n = 34). Presence of suspect axillary lymph nodes on pre-NAC and post-NAC breast MRI was determined by experienced breast radiologists and was correlated to histopathological findings.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the RAD-group residual axillary disease on pathological analysis following NAC was found in 25 patients (39.1%), as compared to 24 patients (70.6%) in the RAD + group (p = 0.003). Metastatic involvement of ARM lymph nodes following NAC was demonstrated in 5 patients (7.8%) in the RAD-group as compared to 10 patients (29.4%) in the RAD + group (p = 0.005).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Breast MRI following NAC is not suitable to detect residual metastatic disease of the axilla. However, breast MRI post-NAC may be of use to identify cN+ patients with a low risk of ARM lymph node metastases. This may help to select a subgroup of cN+ patients in whom sparing of ARM lymph nodes during axillary lymph node dissection can be considered.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Beek</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amphia Hospital, Breda, The Netherlands. Electronic address: MBeek@amphia.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tetteroo</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Radiology, Amphia Hospital, Breda, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luiten</LastName><ForeName>E J T</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amphia Hospital, Breda, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gobardhan</LastName><ForeName>P D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Surgery, Amphia Hospital, Breda, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutten</LastName><ForeName>H J T</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands; Department of Surgery, Maastricht University, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heijns</LastName><ForeName>J B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Oncology, Amphia Hospital, Breda, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voogd</LastName><ForeName>A C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands; Department of Research, Netherlands Comprehensive Cancer Organisation, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klompenhouwer</LastName><ForeName>E G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Department of Radiology, The Netherlands Cancer Institute, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006571">Heterocyclic Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009942">Organometallic Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>99J2XUF1JT</RegistryNumber><NameOfSubstance UI="C050823">gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="N">Contrast Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006571" MajorTopicYN="N">Heterocyclic Compounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020360" MajorTopicYN="N">Neoadjuvant Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018365" MajorTopicYN="N">Neoplasm, Residual</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009942" MajorTopicYN="N">Organometallic Compounds</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Axillary reverse mapping</Keyword><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">Lymphedema</Keyword><Keyword MajorTopicYN="N">MRI</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>08</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26898838</ArticleId><ArticleId IdType="pii">S0748-7983(16)00099-8</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2016.02.005</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country></list><tree><country name="Pays-Bas"><noRegion><name sortKey="Beek, M A" sort="Beek, M A" uniqKey="Beek M" first="M A" last="Beek">M A Beek</name></noRegion><name sortKey="Gobardhan, P D" sort="Gobardhan, P D" uniqKey="Gobardhan P" first="P D" last="Gobardhan">P D Gobardhan</name><name sortKey="Heijns, J B" sort="Heijns, J B" uniqKey="Heijns J" first="J B" last="Heijns">J B Heijns</name><name sortKey="Klompenhouwer, E G" sort="Klompenhouwer, E G" uniqKey="Klompenhouwer E" first="E G" last="Klompenhouwer">E G Klompenhouwer</name><name sortKey="Luiten, E J T" sort="Luiten, E J T" uniqKey="Luiten E" first="E J T" last="Luiten">E J T. Luiten</name><name sortKey="Rutten, H J T" sort="Rutten, H J T" uniqKey="Rutten H" first="H J T" last="Rutten">H J T. Rutten</name><name sortKey="Tetteroo, E" sort="Tetteroo, E" uniqKey="Tetteroo E" first="E" last="Tetteroo">E. Tetteroo</name><name sortKey="Voogd, A C" sort="Voogd, A C" uniqKey="Voogd A" first="A C" last="Voogd">A C Voogd</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A03 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000A03 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:26898838
|texte= Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:26898838" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |